Glucose Tolerance Test

"Glucose Tolerance Test" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg).

Descriptor ID	D005951
MeSH Number(s)	E01.370.225.124.100.355 E01.370.374.355 E05.200.124.100.355
Concept/Terms	Glucose Tolerance Test Glucose Tolerance Test Glucose Tolerance Tests Oral Glucose Tolerance Test Oral Glucose Tolerance Test OGTT Oral Glucose Tolerance Glucose Tolerance, Oral Intravenous Glucose Tolerance Test Intravenous Glucose Tolerance Test Intravenous Glucose Tolerance

Below are MeSH descriptors whose meaning is more general than "Glucose Tolerance Test".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Diagnostic Techniques and Procedures [E01.370]
Clinical Laboratory Techniques [E01.370.225]
Clinical Chemistry Tests [E01.370.225.124]
Blood Chemical Analysis [E01.370.225.124.100]
Glucose Tolerance Test [E01.370.225.124.100.355]
Diagnostic Techniques, Endocrine [E01.370.374]
Glucose Tolerance Test [E01.370.374.355]
Investigative Techniques [E05]
Clinical Laboratory Techniques [E05.200]
Clinical Chemistry Tests [E05.200.124]
Blood Chemical Analysis [E05.200.124.100]
Glucose Tolerance Test [E05.200.124.100.355]

Below are MeSH descriptors whose meaning is related to "Glucose Tolerance Test".

Below are MeSH descriptors whose meaning is more specific than "Glucose Tolerance Test".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Glucose Tolerance Test" by people in this website by year, and whether "Glucose Tolerance Test" was a major or minor topic of these publications.

Bar chart showing 149 publications over 28 distinct years, with a maximum of 12 publications in 2009

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1992	0	3	3
1995	0	2	2
1996	1	0	1
1997	0	1	1
1999	1	1	2
2000	1	1	2
2001	0	1	1
2002	1	6	7
2003	1	4	5
2004	0	7	7
2005	0	4	4
2006	0	5	5
2007	0	3	3
2008	2	6	8
2009	0	12	12
2010	0	5	5
2011	1	6	7
2012	0	10	10
2013	3	4	7
2014	0	7	7
2015	1	6	7
2016	1	8	9
2017	1	6	7
2018	3	7	10
2019	0	4	4
2020	2	5	7
2021	1	4	5
2022	0	1	1

Below are the most recent publications written about "Glucose Tolerance Test" by people in Profiles.

Nathan BM, Redondo MJ, Ismail H, Jacobsen L, Sims EK, Palmer J, Skyler J, Bocchino L, Geyer S, Sosenko JM. Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes. Diabetes Care. 2022 02 01; 45(2):311-318.

View in: PubMed
Mao H, Li L, Fan Q, Angelini A, Saha PK, Coarfa C, Rajapakshe K, Perera D, Cheng J, Wu H, Ballantyne CM, Sun Z, Xie L, Pi X. Endothelium-specific depletion of LRP1 improves glucose homeostasis through inducing osteocalcin. Nat Commun. 2021 09 06; 12(1):5296.

View in: PubMed
Berezowsky A, Raban O, Aviram A, Zafrir-Danieli H, Krispin E, Hadar E. Glucose tolerance test with a single abnormal value in pregnancy and the risk of type-2 diabetes mellitus. Arch Gynecol Obstet. 2022 04; 305(4):869-875.

View in: PubMed
Voss MG, Cuthbertson DD, Cleves MM, Xu P, Evans-Molina C, Palmer JP, Redondo MJ, Steck AK, Lundgren M, Larsson H, Moore WV, Atkinson MA, Sosenko JM, Ismail HM. Time to Peak Glucose and Peak C-Peptide During the Progression to Type 1 Diabetes in the Diabetes Prevention Trial and TrialNet Cohorts. Diabetes Care. 2021 10; 44(10):2329-2336.

View in: PubMed
Redondo MJ, Nathan BM, Jacobsen LM, Sims E, Bocchino LE, Pugliese A, Schatz DA, Atkinson MA, Skyler J, Palmer J, Geyer S, Sosenko JM. Index60 as an additional diagnostic criterion for type 1 diabetes. Diabetologia. 2021 04; 64(4):836-844.

View in: PubMed
Bounds FL, Rojjanasrirat W, Martin MA. Team-Based Approach to Managing Postpartum Screening of Women with Gestational Diabetes for Type 2 Diabetes. J Midwifery Womens Health. 2021 01; 66(1):101-107.

View in: PubMed
Blesson CS, Schutt AK, Vipin VA, Tanchico DT, Mathew PR, Balakrishnan M, Betancourt A, Yallampalli C. In utero low-protein-diet-programmed type 2 diabetes in adult offspring is mediated by sex hormones in rats†. Biol Reprod. 2020 10 29; 103(5):1110-1120.

View in: PubMed
Krispin E, Ashkenazi Katz A, Shmuel E, Toledano Y, Hadar E. Characterization of women with gestational diabetes who failed to achieve glycemic control by lifestyle modifications. Arch Gynecol Obstet. 2021 03; 303(3):677-683.

View in: PubMed
Kim JY, Tfayli H, Bacha F, Lee S, Gebara N, Arslanian S. ß-cell impairment and clinically meaningful alterations in glycemia in obese youth across the glucose tolerance spectrum. Metabolism. 2020 11; 112:154346.

View in: PubMed
Jensen ET, Bertoni AG, Crago OL, Hoffman KL, Wood AC, Arzumanyan Z, Lam LK, Roll K, Sandow K, Wu M, Rich SS, Rotter JI, Chen YI, Petrosino JF, Goodarzi MO. Rationale, design and baseline characteristics of the Microbiome and Insulin Longitudinal Evaluation Study (MILES). Diabetes Obes Metab. 2020 11; 22(11):1976-1984.

View in: PubMed

People

Explore

Similar Concepts

Top Journals